N-(2-oxazolo[5,4-b]pyridin-2-yl-phenyl)-benzamide | 52334-23-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-oxazolo[5,4-b]pyridin-2-yl-phenyl)-benzamide
• 英文别名: 2-(2-benzoylaminophenyl)oxazolo[ 5,4-b]pyridine；2-(2-Benzoylaminophenyl)oxazolo[5,4-b]pyridine；N-[2-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]benzamide
• CAS: 52334-23-3
• 化学式: C₁₉H₁₃N₃O₂
• 分子量: 315.331
• InChiKey: PFXQCZZAMRFQIH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-(2-nitro-phenyl)oxazolo<5,4-b>pyridine 在 钯 作用下， 以 吡啶 、 乙醇 为溶剂， 生成 N-(2-oxazolo[5,4-b]pyridin-2-yl-phenyl)-benzamide
  参考文献：
  名称：

  Anti-inflammatory oxazole[4,5-b]pyridines

  摘要：

  氧唑和噻唑吡啶的各种异构体，具有抗炎、退热和镇痛作用，通过将适当的氨基-羟基吡啶或氨基-巯基吡啶与羧酸、卤化物或酐进行缩合制备。

  公开号：

  US04038396A1

文献信息

• Sirtuin polymorphisms and methods of use thereof
  申请人：Laakso Markku

  公开号：US20080249103A1

  公开（公告）日：2008-10-09

  Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound and/or subjects that are suffering from or susceptible to a disease mediated by a sirtuin. Also provided are methods for determining the predictive value of a sirtuin polymorphic variant, methods for evaluating sirtuin modulating compounds, and methods for determining appropriate dosage and/or treatment regimens for subjects having one or more sirtuin polymorphic variants. Screening methods for identifying sirtuin modulating compounds using polymorphic variants of a sirtuin are also provided.

  本文提供了使用sirtuins的多态性变体进行诊断和预后的方法。这种多态性可能被用来识别对sirtuin调节化合物治疗有响应的受试者，以及患有或易受sirtuin介导疾病影响的受试者。还提供了确定sirtuin多态性变体预测价值的方法，评估sirtuin调节化合物的方法，以及确定具有一个或多个sirtuin多态性变体的受试者的适当剂量和/或治疗方案的方法。还提供了使用sirtuin的多态性变体筛选识别sirtuin调节化合物的筛选方法。
• Anti-inflammatory oxazolo [5,4-b]pyridines
  申请人：Merck & Co., Inc.

  公开号：US04131677A1

  公开（公告）日：1978-12-26

  The various isomers of oxazolo- and thiazolopyridines having utility as antiinflammatory, antipyretic and analgesic agents are prepared by condensation of an appropriate amino-hydroxypyridine or amino-mercaptopyridine with a carboxylic acid, halide or anhydride.

  具有抗炎、退热和镇痛作用的氧唑烷和噻唑烷吡啶的各种异构体是通过将适当的氨基-羟基吡啶或氨基-巯基吡啶与羧酸、卤化物或酐缩合制备而成。
• Sirtuin modulating compounds
  申请人：Nunes J. Joseph

  公开号：US20070037809A1

  公开（公告）日：2007-02-15

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新型的sirtuin调节化合物及其使用方法。这些sirtuin调节化合物可用于增加细胞寿命，并治疗和/或预防各种疾病和疾病，包括与衰老或应激有关的疾病或疾病，糖尿病，肥胖症，神经退行性疾病，心血管疾病，血液凝块性疾病，炎症，癌症和/或红斑病，以及需要增加线粒体活性的疾病或疾病。还提供了包含sirtuin调节化合物和另一种治疗剂的组合物。
• SIRTUIN MODULATING COMPOUNDS
  申请人：Nunes Joseph J.

  公开号：US20120197013A1

  公开（公告）日：2012-08-02

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新颖的调节沉默信息调节因子（sirtuin）的化合物及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并用于治疗和/或预防多种疾病和障碍，包括与衰老或应激有关的疾病或障碍、糖尿病、肥胖症、神经退行性疾病、心血管疾病、血液凝结障碍、炎症、癌症和/或潮红，以及需要增加线粒体活性的疾病或障碍。还提供了包含sirtuin调节化合物与另一种治疗药物组合的组合物。
• Compositions and methods for modulating metabolic pathways
  申请人：NuSirt Sciences, Inc.

  公开号：US10383837B2

  公开（公告）日：2019-08-20

  Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.

  本文提供了有助于诱导脂肪酸氧化或线粒体生物生成增加、减少体重增加、诱导减肥或增加 Sirt1、Sirt3 或 AMPK 活性的组合物和方法。此类组合物可含有协同增效量的sirtuin-途径激活剂，包括但不限于白藜芦醇，与β-羟甲基丁酸（HMB）、酮异己酸（KIC）、亮氨酸或HMB、KIC和亮氨酸的组合物结合使用。